The characterization of the effect of locally applied N- methylquipazine, a 5-HT3 receptor agonist, on extracellular dopamine levels in the anterior medial prefrontal cortex in the rat: An in vive microdialysis study

Synapse

Volumn 24, Issue 4, 1996, Pages 313-321

  Kurata, Kenichi ^a   Ashby Jr , Charles R ^b   Oberlender, Robert ^c   Tanii, Yasuyuki ^a   Kurachi, Masayoshi ^a   Rini, Nancy J ^d   Strecker, Robert E ^d  

^a UNIVERSITY OF TOYAMA   (Japan)

^b ST JOHN'S UNIVERSITY   (United States)

^c UNIVERSITY OF THE PACIFIC   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

5 HT3 agonist; Dopamine; Medial prefrontal cortex; Microdialysis

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; CALCIUM CHLORIDE; CALCIUM ION; DOPAMINE; EDETIC ACID; METIROSINE; N METHYLQUIPAZINE; RICASETRON; SEROTONIN AGONIST; TETRODOTOXIN; UNCLASSIFIED DRUG; VANOXERINE; ZACOPRIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG RECEPTOR BINDING; MALE; MICRODIALYSIS; MOLECULAR INTERACTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ALPHA-METHYLTYROSINE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; DOPAMINE; INDOLES; MALE; MICRODIALYSIS; PREFRONTAL CORTEX; QUIPAZINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TIME FACTORS;

EID: 0029949146     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199612)24:4<313::AID-SYN1>3.0.CO;2-G     Document Type: Article

References (35)

1. Andersen, P.H. (1989) The dopamine uptake inhibitor GBR 12909: Selectivity and molecular mechanism of action. Eur. J. Pharmacol., 166:493-504.
2. 3 receptors in the rat medial prefrontal cortex. Brain Res., 550:161-171.
3. Azmitia, E.C., and Segal, M. (1978) An autoradiographical analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol., 179:641-667.
4. Benes, F.M., Davidson, J., and Bird, E.D. (1986) Quantitative cytoarchitectural studies of the cerebral cortex in schizophrenics. Arch. Gen. Psychiatr., 93:31-35.
5. 4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: Effect of substituted benzamide derivatives. Mol. Pharmacol., 37:408-411.
6. 3 receptor antagonist with anxiolytic-like properties. Psychopharmacology, 110:257-264.
7. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res., 543:353-357.
8. 3 receptor activation in medial prefrontal cortex of freely moving rats. Synapse, 10:264-266.
9. 2 receptor antagonist. Soc. Neurosci. Abstr., 427:19.
10. 3H]-LY278584. Brain Res., 553:149-154.
11. 3 serotonin receptors: Results of a structure-affinity study. Eur. J. Pharmacol., 168:387-392.
12. Goeders, N.B., and Smith, J.E. (1983) Cortical dopaminergic involvement in cocaine reinforcement. Science, 221:772-775.
13. Goeders, N.E., Dworkin, S.I., and Smith, J.E. (1986) Neuropharmacological assessment of cocaine self-administration into the medial prefrontal cortex. Pharmacol. Biochem. Behav., 25:191-199.
14. Hernandez, L., Guzman, N.A., and Hoebel, B.G. (1991) Bidirectional microdialysis in vivo shows differential potency of cocaine, procaine and lidocaine in the nucleus accumbens using capillary electrophoresis for calibration of drug outward diffusion. Psychopharmacology, 105:264-268.
15. 3 receptors control dopamine release in the nucleus accumbens of freely moving rats. Neurosci. Lett., 101:214-217.
16. Jensen, J.A., and Pedersen, E.R. (1987) A new synthesis of quipazine and its n-methyl derivatives. Arch. Pharmacol. (Weinheim), 320:1088-1092.
17. 3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: An in vivo chronacoulometric study. Brain Res., 513:156-160.
18. 3 receptors in rat brain using radioligand binding. Nature, 330:746-748.
19. Lindvall, O., Bjorklund, A., and Divac, I. (1978) I. Organization of dopamine neurons in the medial prefrontal cortex in the rat. Brain Res., 142:1-24.
20. 3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens. Pharmacol. Biochem. Behav., 45:759-761.
21. Naharashi, T. (1974) Chemical tools in the study of excitable membranes. Physiol. Rev., 54:813-889.
22. Oades, R.D., and Halliday, G.M. (1987) Ventral tegmental (A10) system: Neurobiology. 1. Anatomy and connectivity. Brain Res. Rev., 12:117-165.
23. Paxinos, G., and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
24. Rothman, R.B., Mele, A., Reid, A.A., Akunne, H.C., Grieg, N., Thurkauf, A., De Costa, B.R., Rice, K.C., and Pert, A. (1991) GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol. Biochem. Behav., 40:387-397.
25. Routtenberg, A., and Sloan, M. (1972) Self-stimulation in the frontal cortex of Rattus norvegicus. Behav. Biol., 7:567-572.
26. 3]dopamine. Eur. J. Pharmacol., 167:309-310.
27. Schmidt, C.J., and Fadayel, G.M. (1995) The selective 5-HT2A receptor antagonist, MDL 100907, increases dopamine efflux in the prefrontal cortex of the rat. Eur. J. Pharmacol., 273:273-279.
28. 3 antagonist. J. Pharm. Pharmacol., 40:301-302.
29. 3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex. Psychopharmacology, 119:15-19.
30. 3 receptor antagonist. J. Psychopharmacology, 4:289.
31. Van der Zee, P., Koger, H.S., Gootjes, J., and Hespe, W. (1980) Aryl 1,4-dialk(en)yl-piperazines as selective and very potent inhibitors of dopamine uptake. Eur. J. Med. Chem., 15:363-370.
32. 3-like receptors in the medial prefrontal cortex. In: P.B. Bradley, S.L. Handley, S.J. Cooper, B.J. Keys, N.M. Barnes, and J.H. Coote, eds. Serotonin, CNS Receptors and Brain Function. Advances in the Biosciences, 85:81-96.
33. Weinberger, D.R., Berman, K.F., and Zec, R.F. (1986) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. Arch. Gen. Psychiatr., 43:114-124.
34. Weissman, A., Koe, B.K., and Tenen, S.S. (1966) Antiamphetamine effects following inhibition of tyrosine hydroxylase. J. Pharmacol. Exp. Ther., 151:339-352.
35. Westerink, B.H.C., Tuntler, J., Damsma, G., Rollema, H., and de Vries, J.B. (1987) The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn-Schmied. Arch. Pharmacol., 336:502-507.